Gene · 353
Papers3,627
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,627
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Validating a measure for eco-anxiety in Portuguese young adults and exploring its associations with environmental action. | BMC Public Health | 2023 | 37784133 | PubTator, text mining | PubMed |
| ABL1 and ABL2 promote medulloblastoma leptomeningeal dissemination. | Neurooncol Adv | 2023 | 37781087 | PubTator, text mining | PubMed |
| Development and validation of prognostic index based on purine metabolism genes in patients with bladder cancer. | Front Med (Lausanne) | 2023 | 37780567 | PubTator, text mining | PubMed |
| Spatiotemporal Regulation of De Novo and Salvage Purine Synthesis during Brain Development. | eNeuro | 2023 | 37770184 | PubTator, text mining | PubMed |
| A 54 µW CMOS Auto-Trimming Bandgap References (ATBGR) Achieving 90 dB PSRR for Artificial Intelligence of Things (AIoT) Chips. | Micromachines (Basel) | 2023 | 37763888 | PubTator, text mining | PubMed |
| Concordance of Targeted Sequencing from Circulating Tumor DNA and Paired Tumor Tissue for Early Breast Cancer. | Cancers (Basel) | 2023 | 37760445 | PubTator, text mining | PubMed |
| Red Blood Cells from Individuals with Lesch-Nyhan Syndrome: Multi-Omics Insights into a Novel S162N Mutation Causing Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency. | Antioxidants (Basel) | 2023 | 37760001 | PubTator, text mining | PubMed |
| Hypoxanthine phosphoribosyl transferase 1 metabolizes temozolomide to activate AMPK for driving chemoresistance of glioblastomas. | Nat Commun | 2023 | 37737247 | PubTator, text mining | PubMed |
| The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor Resistance. | Cancer Res | 2023 | 37725704 | PubTator, text mining | PubMed |
| The COVID-19 pandemic reveals the wide-ranging role of biobanks. | Front Public Health | 2023 | 37719742 | PubTator, text mining | PubMed |
| BRCA1 frameshift variants leading to extended incorrect protein C termini. | HGG Adv | 2023 | 37718511 | PubTator, text mining | PubMed |
| Barriers associated with pulse and plant-based meat alternative consumption across sociodemographic groups: a Capability, Opportunity, Motivation, Behaviour model approach. | Front Nutr | 2023 | 37706213 | PubTator, text mining | PubMed |
| Abnormal genetic and epigenetic patterns of m6A regulators associated with tumor microenvironment in colorectal cancer. | Transl Cancer Res | 2023 | 37701104 | PubTator, text mining | PubMed |
| Taxane chemotherapy induces stromal injury that leads to breast cancer dormancy escape. | PLoS Biol | 2023 | 37699010 | PubTator, text mining | PubMed |
| Functional evaluation allows ACMG/AMP-based re-classification of CNGA3 variants associated with achromatopsia. | Genet Med | 2023 | 37689994 | PubTator, text mining | PubMed |
| Enhancing Electrical Generation Efficiency through Parametrical Excitation and Slapping Force in Nonlinear Elastic Beams for Vibration Energy Harvesting. | Sensors (Basel) | 2023 | 37688065 | PubTator, text mining | PubMed |
| Exercise training attenuates skeletal muscle fat infiltration and improves insulin pathway of patients with immune-mediated necrotizing myopathies and dermatomyositis. | Arch Rheumatol | 2023 | 37680507 | PubTator, text mining | PubMed |
| A standardised protocol for relative SARS-CoV-2 variant severity assessment, applied to Omicron BA.1 and Delta in six European countries, October 2021 to February 2022. | Euro Surveill | 2023 | 37676146 | PubTator, text mining | PubMed |
| Inflammatory Bowel Sugar Disease: A Pause From New Pharmacological Agents and an Embrace of Natural Therapy. | Cureus | 2023 | 37664383 | PubTator, text mining | PubMed |
| Sex differences in brain protein expression and disease. | Nat Med | 2023 | 37653343 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/353/papers?page=10